Brief: Polarityte Inc Says Diabetic Foot Ulcer Trial Met Primary And Secondary Endpoint
10/05/2021 13:43
May 10 (Reuters) - PolarityTE Inc PTE.O :
* POLARITYTE INC - DIABETIC FOOT ULCER TRIAL MET PRIMARY AND
SECONDARY ENDPOINT
Source text for Eikon: ID:nBw90Qv8na
Further company coverage: PTE.O
((reuters.briefs@thomsonreuters.com;))
Recent news on RegenETP,
See all newsBrief: PolarityTE Receives Delisting Notice From Nasdaq
U.S. STOCKS ON THE MOVE-Biogen, Phoenix Motor, Mastercard
U.S. STOCKS ON THE MOVE-Energy sector, Affirm, Stitch Fix
U.S. STOCKS ON THE MOVE-Shutterstock, Salesforce, Plug Power
Brief: Polarityte And Its Subsidiaries Files Voluntary Petitions For Relief Under Chapter 11